Index Entries

B. Pla Peris, A. Á. Merchante Alfaro, F. J. Maravall Royo, P. Abellán Galiana, S. Pérez Naranjo, and M. González Boillos
January 11, 2022
Journal of Endocrinological Investigation
Hospital General Universitario de Castellón (Spain)

Results: We report 8 cases with thyrotoxicosis after SARS-CoV-2 vaccination. 4 cases of Graves’ disease (GD), 2 cases of subacute painful thyroiditis (SAT), 1 case of concurrent GD and SAT and 1 case of atypical subacute thyroiditis. Five patients received BNT162b2 mRNA vaccine, 3 patients 1273 mRNA vaccine. The onset of symptoms following vaccination ranged from 10 to 14 days in six of eight patients and from 7 to 8 weeks in two patients.

Conclusions: Several hypotheses have been proposed to explain the potential correlation between SARS-CoV-2 vaccination and thyrotoxicosis, including immune system hyper-stimulation, molecular mimicry and Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). We should pay greater attention to thyroid disorders in patients receiving vaccine against SARS-CoV-2.”

document
adverse events,autoimmunity,COVID-19,vaccines